The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk

Cancer

Volumn 112, Issue 11, 2008, Pages 2409-2416

  Wen, Wanqing ^a,c   Cai, Qiuyin ^a   Xiang, Yong Bing ^b   Xu, Wang Hong ^b   Zhi, Xian Ruan ^b   Cheng, Jiarong ^b   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; Endometrial cancer; Insulin resistance; Obesity

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANCER REGISTRY; CANCER RISK; CHINA; CLIMACTERIUM; CONTROL GROUP; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN RESISTANCE; INTERVIEW; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO; CASE CONTROL STUDY; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; GENETICS; MIDDLE AGED; PREMENOPAUSE; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE; RISK FACTORS; WAIST-HIP RATIO;

EID: 52049104950     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23453     Document Type: Article

References (35)

1. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2005;14:2840-2847.
2. Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006;106:2376-2381.
3. Iwasaki T, Nakajima A, Yoneda M, Terauchi Y. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocr J. 2006;53: 345-356.
4. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69:29-35.
5. Chang SC, Lacey JV Jr, Brinton LA, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 2007;16:723-730.
6. Friedenreich C, Cust A, Lahmann PH, et al. Anthropometric factors and risk of endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control. 2007;18:399-413.
7. Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingleton HM. Endometrial cancer, obesity, and body fat distribution. Cancer Res. 1991;51:568-572.
8. Goodman MT, Hankin JH, Wilkens LR, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res. 1997;57:5077-5085.
9. Shu XO, Brinton LA, Zheng W, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res. 1992;52:3865-3870.
10. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487-48490.
11. Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005; 77:64-77.
12. Miller DT, Zee RY, Suk DJ, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005;69:623-638.
13. Suk DJ, Chasman DI, Cannon CP, et al. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet. 2006;70:705-716.
14. Szalai AJ, Wu J, Lange EM, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med. 2005;83:440-447.
15. Obisesan TO, Leeuwenburgh C, Ferrell RE, et al. C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity. Metabolism. 2006;55:453-460.
16. Wolford JK, Gruber JD, Ossowski VM, et al. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab. 2003; 78:136-144.
17. Xu WH, Matthews CE, Xiang YB, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol. 2005;161:939-947.
18. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217-1223.
19. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106-120.
20. Cai Q, Shu XO, Wen W, et al. Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15: 403-404.
21. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989.
22. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73:1162-1169.
23. Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol. 2005;29:299-312.
24. Zeng D, Lin DY, Avery CL, North KE, Bray MS. Efficient semiparametric estimation of haplotype-disease associations in case-cohort and nested case-control studies. Biostatistics. 2006;7:486-502.
25. Harrell FE Jr. Regression Modeling Strategies, With Application to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
26. Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health (Larchmont).12:163-172, 2003.
27. Gredmark T, Kvint S, Havel G, Mattsson LA. Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol. 1999;72: 138-142.
28. Le ML, Wilkens LR, Mi MP. Early-age body size, adult weight gain and endometrial cancer risk. Int J Cancer. 1991;48:807-811.
29. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 1988;57:205-212.
30. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531-1543.
31. Hursting SD, Nunez NP, Varticovski L, Vinson C. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res. 2007;67:2391-2393.
32. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24:278-301.
33. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792-2800.
34. Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23:2063-2069.
35. Marsik C, Sunder-Plassmann R, Jilma B, et al. The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. Clin Chem. 2006;52:1952-1957.